page contents

Tag Archives: securities

Ginnie Mae announces Platinum product for reverse mortgage-backed securities

Ginnie Mae has launched a new securitization channel for reverse mortgage-backed securities. Now, investors in the HECM mortgage-backed securities, or HMBS, market can participate in Ginnie’s new Platinum HMBS program, which reduces the administrative costs of holding multiple and smaller HMBS securities. The Platinum program will allow broker-dealers to combine HMBS, including tail issuance, into new, larger securities for investors. ...

Read More »

Gibraltar Stock Exchange To Offer Blockchain-based Digital Debt Securities

The Gibraltar Stock Exchange (GSX) is set to list blockchain-powered digital debt securities and digital funds. The new products, known as digital, smart or tokenized securities, include Corporate Bonds, Convertible Bonds, Asset Backed Securities, Derivative Securities, Open-Ended Funds and Closed-Ended Funds. They are listed on GSX Global Market. GSX Global Market is a practical listing venue option for issuers offering ...

Read More »

These are the top issuers of reverse mortgage-backed securities

As reverse mortgage loan production steadily declines, so too has the issuance of the securities backed by this product on the secondary market.  Issuers of HECM-backed securities, or HMBS, brought just under $ 1.7 billion to market in the first quarter of 2019, according to the latest report from New View Advisors. This is a 44% decline from last year and ...

Read More »

BRIEF-Forsys Metals Says Ontario Securities Commission Has Issued Failure-To-File Cease Trade Order

© Reuters. BRIEF-Forsys Metals Says Ontario Securities Commission Has Issued Failure-To-File Cease Trade Order April 5 (Reuters) – Forsys Metals Corp : * CEASE TRADE ORDER AND UPDATE ON FILING OF THE FINANCIAL STATEMENTS * FORSYS METALS CORP – ONTARIO SECURITIES COMMISSION HAS ISSUED A FAILURE-TO-FILE CEASE TRADE ORDER * FORSYS METALS CORP – CONFIRMS THAT THERE IS NO… All ...

Read More »

KESSLER TOPAZ MELTZER & CHECK, LLP – Reminds Investors of Securities Fraud Class Action Lawsuit Against HEALTHCARE SERVICES GROUP, INC. – HCSG

RADNOR, Apr 03, 2019 (GLOBE NEWSWIRE via COMTEX) — The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania against Healthcare Services Group, Inc. <span class="quote up bgQuote" data-channel="/quotes/zigman/73158/compos… Healthcare Industry News

Read More »

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) price target raised to $18.00 by JMP Securities

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) price target raised to $ 18.00 by JMP Securities Apr 02, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Today, JMP Securities raised its price target on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to $ 18.00 per share. There are 6 Buy Ratings, 3 Hold Ratings, no Strong Buy Ratings, no Sell Ratings ...

Read More »

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) price target raised to $18.00 by JMP Securities

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) price target raised to $ 18.00 by JMP Securities Apr 02, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Today, JMP Securities raised its price target on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to $ 18.00 per share. There are 6 Buy Ratings, 3 Hold Ratings, no Strong Buy Ratings, no Sell Ratings ...

Read More »

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) price target raised to $18.00 by JMP Securities

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) price target raised to $ 18.00 by JMP Securities Apr 02, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Today, JMP Securities raised its price target on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to $ 18.00 per share. There are 6 Buy Ratings, 3 Hold Ratings, no Strong Buy Ratings, no Sell Ratings ...

Read More »

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) price target raised to $18.00 by JMP Securities

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) price target raised to $ 18.00 by JMP Securities Apr 02, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Today, JMP Securities raised its price target on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to $ 18.00 per share. There are 6 Buy Ratings, 3 Hold Ratings, no Strong Buy Ratings, no Sell Ratings ...

Read More »

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close